Company / Return on Assets (ROA)
Day One Biopharmaceuticals, Inc. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-21.1%
FY2025
5-year range
-50.2% / -16.4%
FY2021-FY2025
Trend
-28.9%
vs FY2024
Sector context
#105 of 213
Health Care
What the data says
At -21.1%, Day One Biopharmaceuticals, Inc.'s return on assets (roa) ranks #105 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 6 years, ranging from -88.7% in FY2020 to -16.4% in FY2024.
Based on SEC 10-K filings.
-21.1% in FY2025 with a 5-year CAGR of +67.6%.
Improved from -50.2% to -21.1% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +19.6pp
- 5-Year Change
- +67.6pp
- 10-Year Change
- -
Sector benchmark
#105 of 213 in Health CareTop 49% of 213This company -21.1% Sector average -24.1%
▼
+12.2% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 28.9% year-over-year.
- Currently 2.9pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2020.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -21.1% | -28.9% |
| FY2024 | -16.4% | +67.4% |
| FY2023 | -50.2% | -23.3% |
| FY2022 | -40.7% | -62.3% |
| FY2021 | -25.1% | +71.7% |
| FY2020 | -88.7% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026